Skip Navigation


Hum. Reprod. Advance Access originally published online on May 12, 2005
Human Reproduction 2005 20(9):2414-2420; doi:10.1093/humrep/dei070
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/9/2414    most recent
dei070v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yilmaz, M.
Right arrow Articles by Arslan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yilmaz, M.
Right arrow Articles by Arslan, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions{at}oupjournals.org

Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome

Murat Yilmaz1,4, Neslihan Bukan2, Reyhan Ersoy3, Ayhan Karakoç3, Ilhan Yetkin3, Göksun Ayvaz3, Nuri Çakir3 and Metin Arslan3

1 Department of Endocrinology and Metabolism, Kirikkale University Faculty of Medicine, Kirikkale, 2 Department of Biochemistry and 3 Department of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Turkey

4 To whom correspondence should be addressed at: Murat Yilmaz MD Çinar Sokak 77/4, Yenimahalle-Ankara-Turkey. Email: murartt{at}hotmail.com

BACKGROUND: The aim of the present study was to evaluate insulin resistance (IR), glucose tolerance status and cardiovascular risk factors in first degree relatives of patients with polycystic ovary syndrome (PCOS). METHODS: A total of 120 family members [MothersPCOS (n=40), FathersPCOS (n=38), SistersPCOS (n=25) and BrothersPCOS (n=17)] of 55 patients with PCOS and 75 unrelated healthy control subjects without a family history of diabetes or PCOS (four age- and weight-matched subgroups, i.e. ControlMothers, ControlFathers, ControlSisters and ControlBrothers) were studied. IR was assessed by homeostatic model assessment (HOMA IR), log HOMA, insulin sensivity index (ISI), the quantitative insulin sensitivity check index (QUICKI) and area under the curve for insulin during the oral glucose tolerance test (AUCI, AUCG) in with normal glucose tolerance (NGT) subjects and controls. Serum adiponectin, resistin, homocysteine and lipid levels were measured. RESULTS: The prevalence of any degree of glucose intolerance was 40% in MothersPCOS and 52% in FathersPCOS. In total, six (15%) glucose tolerance disorders were identified in the ControlMothers and ControlFathers in first degree relatives of control subjects. The first degree relatives of PCOS patients had significantly higher serum fasting insulin, HOMA-IR, Log HOMA and AUCI levels in all subgroups than the control subjects. The control subjects had significantly elevated QUCKI, ISI levels and serum adiponectin levels compared to the first degree relatives of PCOS subjects in all subgroups. The serum Hcy and resistin levels increased significantly in both FathersPCOS and MothersPCOS groups but not BrothersPCOS and SisterPCOS. CONCLUSION: The results of the present study support the finding that the first degree relatives of PCOS patients carry an increased risk of cardiovascular disease, as do PCOS patients.

Key words: adiponectin/family/homocysteine/insulin resistance/PCOS


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. Sam, A. D. Coviello, Y.-A. Sung, R. S. Legro, and A. Dunaif
Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
Diabetes Care, June 1, 2008; 31(6): 1237 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. F. Witchel
Ontogeny of Polycystic Ovary Syndrome: A Creative Approach
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1576 - 1578.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Urbanek, S. Sam, R. S. Legro, and A. Dunaif
Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association with a Metabolic Phenotype
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4191 - 4198.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller
Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.